Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc."
Results 221 - 240
of 284
Sorted by Relevance
|
Sort by Date
21 Jun 2011, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), applies to class certifications. [read post]
12 Apr 2018, 6:00 am
Merrell Dow Pharmaceuticals, Inc. 509 U.S. 579 (1993), which enumerates the factors a court should consider when admitting expert testimony, along with its progeny, also fails to address what exactly “reasonable degree of certainty” means. [read post]
18 Feb 2020, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) or Frye v. [read post]
31 Oct 2019, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) will consider a non-exhaustive list of factors such as the expert’s methodology and reliability. [read post]
18 Sep 2019, 10:02 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S. [read post]
5 Nov 2007, 12:58 pm
Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1320 (9th Cir. 1995); DeLuca v. [read post]
14 May 2015, 2:15 pm
Merrell Dow Pharmaceuticals and its progeny, permits a district court to require epidemiological evidence as a precondition for admissibility of a qualified expert's opinion that a toxic substance is capable of causing a particular disease. [read post]
5 Jan 2022, 4:33 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993).Where does the universe of disability terminate? [read post]
15 Dec 2009, 1:56 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993)]). [read post]
1 Apr 2011, 3:00 am
Merrell Dow Pharmaceuticals, Inc., 52 Baylor L. [read post]
22 Aug 2013, 1:57 pm
The majority of states have adopted the Daubert standard, though several states refuse to explicitly adopt either Frye or Daubert, but choose to apply similar standards that acknowledge Daubert.[17] IV. [read post]
13 Sep 2019, 6:00 am
[vi]And then-Justice Rehnquist might have joined the majority in Washington v. [read post]
23 Jan 2014, 9:37 am
Merrell Dow Pharmaceuticals, Inc. [read post]
14 Aug 2011, 9:11 am
Merrell Dow Pharms., Inc., 509 U.S. 579 (1993). [read post]
30 Oct 2013, 10:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 599 (1993) (Rehnquist, C.J., concurring in part and dissenting in part) (“the various briefs filed in this case … deal with definitions of scientific knowledge, scientific method, scientific validity, and peer review—in short, matters far afield from the expertise of judges”); Marconi Wireless Telegraph Co. [read post]
28 Oct 2013, 7:19 pm
Merrell Dow Pharmaceuticals, Inc. [read post]
10 Sep 2014, 9:00 am
Merrell Dow Pharmaceuticals regarding important expert testimony requires the appellate court to order a new trial, regardless of whether there was actually any substantive error in the expert testimony heard or not heard by the jury. [read post]
20 Apr 2017, 8:23 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579(1993). [read post]
13 Apr 2007, 8:09 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and Frye v. [read post]
22 Nov 2015, 10:32 pm
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993);see Fed. [read post]
